Sfoglia per Autore
Studying the metabolic activity of red bone marrow by means of FDG-PET: The need for a standardization
2008-01-01 Cicone, F.; Signore, A.; Scopinaro, F.
Prognostic value of FDG uptake by the bone marrow in squamous cell carcinoma of the head and neck
2008-01-01 Cicone, F.; Loose, D.; Deron, P.; Vermeersch, H.; Signore, A.; Van de Vyvere, F.; Scopinaro, F.; Van de Wiele, C.
Tc-99m DTPA cisternography shows disappearance of cerebrospinal fluid leakage after standing a short time
2009-01-01 Del Mastro, Carolina; Cicone, Francesco; D'Andrea, Giancarlo; Scopinaro, Francesco
Radioimmunotherapy of heavily pre-treated, non-Hodgkin's lymphoma patients: efficacy and safety in a routine setting
2009-01-01 Cicone, Francesco; Baldini, Rossella; Cox, Maria Christina; Russo, Eleonora; Torelli, Fabio; Tofani, Anna; Scopinaro, Francesco
A theoretical dose-escalation study based on biological effective dose in radioimmunotherapy with 90Y-ibritumomab tiuxetan (Zevalin)
2010-01-01 Pacilio, M.; Betti, M.; Cicone, F.; Del Mastro, C.; Montani, L.; Chiacchiararelli, L.; Monaco, A.; Santini, E.; Scopinaro, F.
Visual and quantitative approach to bone marrow foci of increased glucose uptake on PET/CT in a case of aplastic anaemia
2010-01-01 Cicone, F.; Stalder, M.; Geiger, D.; Cairoli, A.; Bischof Delaloye, A.; Prior, J. O.
Follicular lymphoma at relapse after rituximab containing regimens: Comparison of time to event intervals prior to and after 90Y-ibritumomab-tiuxetan
2011-01-01 Cicone, F.; Russo, E.; Carpaneto, A.; Prior, J. O.; Delaloye, A. B.; Scopinaro, F.; Ketterer, N.
Rituximab-like radiolabelled antibodies for the treatment of non-hodgkin's lymphomas
2012-01-01 Cicone, F.; Scopinaro, F.
Three-dimensional patient-specific dosimetry in radioimmunotherapy with 90Y-ibritumomab-tiuxetan
2012-01-01 D'Arienzo, M.; Cicone, F.; Chiacchiararelli, L.; Coniglio, A.; Delaloye, A. B.; Scopinaro, F.
Fatal pulmonary tumour thrombotic microangiopathy: do typical FDG-PET findings exist?
2012-01-01 Cicone, F; Del Forno, M; Papa, A; Comito, F; Festa, A; Uccini, S; Scopinaro, F
Quantification of dose nonuniformities by voxel-based dosimetry in patients receiving 90Y-ibritumomab-tiuxetan
2013-01-01 Cicone, F.; D'Arienzo, M.; Carpaneto, A.; Russo, E.; Coniglio, A.; Bischof Delaloye, A.; Scopinaro, F.
Anatomical substrates of cognitive and clinical dimensions in first episode schizophrenia
2013-01-01 Rigucci, S.; Rossi-Espagnet, C.; Ferracuti, S.; De Carolis, A.; Corigliano, V.; Carducci, F.; Mancinelli, I.; Cicone, F.; Tatarelli, R.; Bozzao, A.; Girardi, P.; Comparelli, A.
Malignant Lymphoma in Children
2014-01-01 Cicone, Francesco; Uccini, Stefania
ROLE OF 18F-DOPA PET/CT IN NON-ENHANCING GLIOMAS
2014-01-01 Scaringi, C; Cicone, F; Papa, A; Scopinaro, F; Minniti, G; Maurizi Enrici, R
The importance of standardizing acquisition settings and interpretation criteria of radionuclide cisternography
2014-01-01 Cicone, F.; Mastro, C. D.; Scopinaro, F.
F-DOPA PET identifies high tumor grade and anaplastic transformation in non-enhancing gliomas
2014-01-01 Cicone, F; Scaringi, C; Papa, A; Maurizi Enrici, R; Minniti, G; Scopinaro, F
Imaging the future: A report from the Young Daily EANM Forum 2013
2014-01-01 Cicone, F.; Jamar, F.; Zerizer, I.
Why not consider PET/CT in the workup of pulmonary tumour thrombotic microangiopathy?
2015-01-01 Cicone, F.; Abe, K.
Thyro-gastric autoimmunity in patients with differentiated thyroid cancer: a prospective study
2015-01-01 Cicone, F.; Papa, A.; Lauri, C.; Tofani, A.; Virili, C.; Centanni, M.; Scopinaro, F.; Annibale, B.
Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery
2015-01-01 Cicone, F.; Minniti, G.; Romano, A.; Papa, A.; Scaringi, C.; Tavanti, F.; Bozzao, A.; Maurizi Enrici, R.; Scopinaro, F.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Studying the metabolic activity of red bone marrow by means of FDG-PET: The need for a standardization | 1-gen-2008 | Cicone, F.; Signore, A.; Scopinaro, F. | |
Prognostic value of FDG uptake by the bone marrow in squamous cell carcinoma of the head and neck | 1-gen-2008 | Cicone, F.; Loose, D.; Deron, P.; Vermeersch, H.; Signore, A.; Van de Vyvere, F.; Scopinaro, F.; Van de Wiele, C. | |
Tc-99m DTPA cisternography shows disappearance of cerebrospinal fluid leakage after standing a short time | 1-gen-2009 | Del Mastro, Carolina; Cicone, Francesco; D'Andrea, Giancarlo; Scopinaro, Francesco | |
Radioimmunotherapy of heavily pre-treated, non-Hodgkin's lymphoma patients: efficacy and safety in a routine setting | 1-gen-2009 | Cicone, Francesco; Baldini, Rossella; Cox, Maria Christina; Russo, Eleonora; Torelli, Fabio; Tofani, Anna; Scopinaro, Francesco | |
A theoretical dose-escalation study based on biological effective dose in radioimmunotherapy with 90Y-ibritumomab tiuxetan (Zevalin) | 1-gen-2010 | Pacilio, M.; Betti, M.; Cicone, F.; Del Mastro, C.; Montani, L.; Chiacchiararelli, L.; Monaco, A.; Santini, E.; Scopinaro, F. | |
Visual and quantitative approach to bone marrow foci of increased glucose uptake on PET/CT in a case of aplastic anaemia | 1-gen-2010 | Cicone, F.; Stalder, M.; Geiger, D.; Cairoli, A.; Bischof Delaloye, A.; Prior, J. O. | |
Follicular lymphoma at relapse after rituximab containing regimens: Comparison of time to event intervals prior to and after 90Y-ibritumomab-tiuxetan | 1-gen-2011 | Cicone, F.; Russo, E.; Carpaneto, A.; Prior, J. O.; Delaloye, A. B.; Scopinaro, F.; Ketterer, N. | |
Rituximab-like radiolabelled antibodies for the treatment of non-hodgkin's lymphomas | 1-gen-2012 | Cicone, F.; Scopinaro, F. | |
Three-dimensional patient-specific dosimetry in radioimmunotherapy with 90Y-ibritumomab-tiuxetan | 1-gen-2012 | D'Arienzo, M.; Cicone, F.; Chiacchiararelli, L.; Coniglio, A.; Delaloye, A. B.; Scopinaro, F. | |
Fatal pulmonary tumour thrombotic microangiopathy: do typical FDG-PET findings exist? | 1-gen-2012 | Cicone, F; Del Forno, M; Papa, A; Comito, F; Festa, A; Uccini, S; Scopinaro, F | |
Quantification of dose nonuniformities by voxel-based dosimetry in patients receiving 90Y-ibritumomab-tiuxetan | 1-gen-2013 | Cicone, F.; D'Arienzo, M.; Carpaneto, A.; Russo, E.; Coniglio, A.; Bischof Delaloye, A.; Scopinaro, F. | |
Anatomical substrates of cognitive and clinical dimensions in first episode schizophrenia | 1-gen-2013 | Rigucci, S.; Rossi-Espagnet, C.; Ferracuti, S.; De Carolis, A.; Corigliano, V.; Carducci, F.; Mancinelli, I.; Cicone, F.; Tatarelli, R.; Bozzao, A.; Girardi, P.; Comparelli, A. | |
Malignant Lymphoma in Children | 1-gen-2014 | Cicone, Francesco; Uccini, Stefania | |
ROLE OF 18F-DOPA PET/CT IN NON-ENHANCING GLIOMAS | 1-gen-2014 | Scaringi, C; Cicone, F; Papa, A; Scopinaro, F; Minniti, G; Maurizi Enrici, R | |
The importance of standardizing acquisition settings and interpretation criteria of radionuclide cisternography | 1-gen-2014 | Cicone, F.; Mastro, C. D.; Scopinaro, F. | |
F-DOPA PET identifies high tumor grade and anaplastic transformation in non-enhancing gliomas | 1-gen-2014 | Cicone, F; Scaringi, C; Papa, A; Maurizi Enrici, R; Minniti, G; Scopinaro, F | |
Imaging the future: A report from the Young Daily EANM Forum 2013 | 1-gen-2014 | Cicone, F.; Jamar, F.; Zerizer, I. | |
Why not consider PET/CT in the workup of pulmonary tumour thrombotic microangiopathy? | 1-gen-2015 | Cicone, F.; Abe, K. | |
Thyro-gastric autoimmunity in patients with differentiated thyroid cancer: a prospective study | 1-gen-2015 | Cicone, F.; Papa, A.; Lauri, C.; Tofani, A.; Virili, C.; Centanni, M.; Scopinaro, F.; Annibale, B. | |
Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery | 1-gen-2015 | Cicone, F.; Minniti, G.; Romano, A.; Papa, A.; Scaringi, C.; Tavanti, F.; Bozzao, A.; Maurizi Enrici, R.; Scopinaro, F. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile